Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancer02:18

Cancer

53.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fucoidan from Costaria costata alleviated dextran sulfate sodium-induced ulcerative colitis by suppressing dendritic cell activation.

International journal of biological macromolecules·2026
Same author

GENRISE-induced superior extracellular vesicles for scalable therapeutic cargo delivery.

Science advances·2025
Same author

Nasal Administration of <i>Durvillaea antarctica</i> Fucoidan Inhibits Lung Cancer Growth in Mice Through Immune Activation.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Fucoidan from Durvillaea Antarctica elicits anticancer immunity against lung cancer via natural killer cell activation.

International journal of biological macromolecules·2025
Same author

Dysregulated Bone Marrow Contributes to Glomerular Injury through Soluble Factors.

Journal of the American Society of Nephrology : JASN·2025
Same author

Tolerogenic Dendritic Cell- and M2 Macrophage Polarization-Inducible Hybrid Nanoparticles Alleviate Asthma in Mice.

ACS nano·2025
Same journal

Probabilistic RNA designability via interpretable ensemble approximation and dynamic decomposition.

Bioinformatics (Oxford, England)·2026
Same journal

Quantifying domain-specific relevance of computational biology Wikipedia articles using TF-IDF and cosine similarity.

Bioinformatics (Oxford, England)·2026
Same journal

GATSBI: improving context-aware protein embeddings through biologically motivated data splits.

Bioinformatics (Oxford, England)·2026
Same journal

BiMba: using Vision Mamba to predict protein sites that bind other proteins.

Bioinformatics (Oxford, England)·2026
Same journal

ProMeta: a meta-learning framework for robust disease diagnosis and prediction from plasma proteomics.

Bioinformatics (Oxford, England)·2026
Same journal

Is a Win-Win possible? Achieving pareto-optimal privacy-utility balance in fine-tuned genome language model embeddings against embedding reconstruction attacks.

Bioinformatics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jan 5, 2026

Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties
08:19

Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties

Published on: May 19, 2023

2.3K

Cancer classification of single-cell gene expression data by neural network.

Bong-Hyun Kim1,2, Kijin Yu1, Peter C W Lee1

  • 1Department of Biomedical Sciences, University of Ulsan College of Medicine, ASAN Medical Center, Seoul 05505, Korea.

Bioinformatics (Oxford, England)
|October 12, 2019
PubMed
Summary
This summary is machine-generated.

This study developed a neural network (NN) model for accurate cancer classification using gene expression data from The Cancer Genome Atlas (TCGA). The NN model effectively identified 21 cancer types and normal tissues from both bulk and single-cell RNA sequencing data.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.9K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.6K

Related Experiment Videos

Last Updated: Jan 5, 2026

Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties
08:19

Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties

Published on: May 19, 2023

2.3K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.9K
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.6K

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • Gene expression profiles are crucial for understanding cancer and guiding treatment.
  • Single-cell RNA sequencing (scRNA-seq) presents challenges in gene expression analysis due to data variability.
  • Machine learning approaches are increasingly used for downstream cancer analysis.

Purpose of the Study:

  • To design and evaluate machine learning models for classifying 21 cancer types and normal tissues.
  • To compare the performance of different machine learning algorithms, including neural networks (NN), support vector machines (SVM), k-nearest neighbors (kNN), and random forests (RF).
  • To adapt the classification model for single-cell RNA sequencing data.

Main Methods:

  • Developed cancer classifiers utilizing gene expression data from The Cancer Genome Atlas (TCGA).
  • Trained models on 7398 cancer and 640 normal samples, focusing on the 300 most significant genes per cancer type.
  • Compared NN, SVM, kNN, and RF algorithms for classification performance.
  • Applied the optimized model to scRNA-seq data after kNN smoothing.

Main Results:

  • The neural network (NN) model demonstrated superior and consistent performance compared to SVM, kNN, and RF.
  • The developed classifier successfully identified 21 distinct cancer types and normal tissue samples.
  • The approach was effectively applied to processed scRNA-seq data, maintaining high classification accuracy.

Conclusions:

  • Neural network-based classification of gene expression profiles is a robust method for cancer type identification.
  • The developed NN model offers a reliable tool for classifying both bulk and single-cell RNA sequencing data.
  • This approach enhances cancer diagnostics and aids in understanding cancer heterogeneity.